CRVO ▲ +6.3% - CervoMed Inc.
$CRVO - CervoMed Announces Pharmacokinetic Results with New Neflamapimod Oral Tablet Formulation and Secures FDA Removal of Drug Exposure Limit
28-SEP-2026 07:30 AM ET
Share this post
More filings for $CRVO
CRVO ▼ -0.4% - CervoMed Inc.Sep 22, 2026CRVO ▲ +1.6% - CervoMed Inc.Sep 10, 2026CRVO ▲ +0.8% - CervoMed Inc.Sep 8, 2026CRVO - CervoMed Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026CRVO - CervoMed Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026CRVO - CervoMed Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026
View full $CRVO filing history →💬 Comments
Loading comments…
Leave a comment